Menta Capital’s Lifecore Biomedical LFCR Stock Holding History

Menta Capital’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,813	Closed	-$170K	–	759
2015 Q2	$170K	Buy	+11,813	New	+$170K	0.03%	605

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Menta Capital's LFCR Position: Q3 2015 in Review

Menta Capital sold out of Lifecore Biomedical (LFCR) in Q3 2015, closing a stake of 11,813 shares — an estimated $170K sold.

Menta Capital first reported a position in LFCR in Q2 2015 and held it in 1 quarter. The position peaked at $170K in Q2 2015. 111 funds tracked by Wall St. Rank hold LFCR as of Q3 2015.

Menta Capital reported no remaining Lifecore Biomedical position as of Q3 2015 after selling out during the quarter.
Menta Capital sold 11,813 Lifecore Biomedical shares in Q3 2015, an estimated $170K.
Menta Capital first reported a position in Lifecore Biomedical in Q2 2015 and held it in 1 quarter.
Menta Capital's Lifecore Biomedical position peaked at $170K in Q2 2015.
111 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2015.

Based on Menta Capital's 13F filing for Q3 2015, filed 12 Nov 2015.